Gene content  |
| ERBB2 ( by HUGO) |
| V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog... |
| Oncogene |
| V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 NGL HER2 NEU Neuro/Glioblastoma Derived Oncogene Homolog Metastatic Lymph Node Gene 19 Protein Proto-Oncogene C-ErbB-2 Proto-Oncogene Neu Tyrosine Kinase-Type Cell Surface Receptor HER2 MLN 19 p185erbB2 EC 2.7.10.1 V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (Neuro/Glioblastoma Derived Oncogene Homolog) CD340 HER-2 HER-2/neu TKR1 C-Erb B2/Neu Protein herstatin Neuroblastoma/Glioblastoma Derived Oncogene Homolog Receptor Tyrosine-Protein Kinase ErbB-2 V-Erb-B2 Erythroblastic Leukemia Viral Oncogene Homolog 2 Neuro/Glioblastoma Derived Oncogene Homolog MLN19 CD340 Antigen EC 2.7.10 |
| NCBI: 17q12 Ensembl: 17q12 |
|
Subunit: Homodimer. Heterodimer with EGFR, ERBB3 and ERBB4. Part of a complex with EGFR and either PIK3C2A or PIK3C2B. May interact with PIK3C2B when phosphorylated on Tyr-1196. Interacts with PRKCABP and PLXNB1. Interacts (when phosphorylated on Tyr-1248) with MEMO1. Interacts with MUC1; the interaction is enhanced by heregulin (HRG). Interacts (when phosphorylated on Tyr-1139) with GRB7 (via SH2 domain). Interacts (when phosphorylated on Tyr-1248) with ERBB2IP. Interacts with KPNB1, RANBP2, EEA1, CRM1, CLTC, PTK6, RPA94 and ACTB. Interacts with SRC (By similarity) Selected PDB 3D structures from [IMAGE] and Proteopedia [IMAGE] for ERBB2 (see all 21): 1MFG (3D) [IMAGE] 1MFL (3D) [IMAGE] 1MW4 (3D) [IMAGE] 1N8Z (3D) [IMAGE] 1OVC (3D) [IMAGE] 1QR1 (3D) [IMAGE]
Tissue specificity: Expressed in a variety of tumor tissues including primary breast tumors and tumors from small bowel, esophagus, kidney and mouth [IMAGE] Pathway & Disease-focused RT2 Profiler PCR Arrays including ERBB2 (see all 13): Oncogenes & Tumor Suppressor Genes in
Function: In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization Function: In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth
Catalytic activity: ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate
Similarity: Belongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily Contains 1 protein kinase domain [IMAGE]
|
| Protein Domain/Family |
| Source |
ID |
Domain |
Name |
Type |
| InterPro | IPR000494 | EGF_rcpt_L | Epidermal growth-factor receptor (EGFR), L domain | Domain
|
| IPR000719 | Prot_kinase_dom | Protein kinase | Domain
|
| IPR001245 | Ser-Thr/Tyr_kinase_cat_dom | Tyrosine protein kinase | Domain
|
| IPR006211 | Furin-like_Cys-rich_dom | Furin-like cysteine rich region | Domain
|
| IPR006212 | Furin_repeat | Furin-like repeat | Repeat
|
| IPR008266 | Tyr_kinase_AS | Tyrosine protein kinase, active site | Active Sites
|
| IPR009030 | Growth_fac_rcpt_N_dom | Growth factor, receptor | Domain
|
| IPR011009 | Kinase-like_dom | Protein kinase-like | Domain
|
| Blocks | IPB000494 | Epidermal growth-factor receptor (EGFR) | Epidermal growth-factor receptor (EGFR), L domain |
| IPB000494 | Epidermal growth-factor receptor (EGFR) | Epidermal growth-factor receptor (EGFR), L domain |
| IPB000494 | Epidermal growth-factor receptor (EGFR) | Epidermal growth-factor receptor (EGFR), L domain |
| IPB000494 | Epidermal growth-factor receptor (EGFR) IPB004019 YLP motif IPB008266 Tyrosine protein kinase | Epidermal growth-factor receptor (EGFR), L domain |
| IPB006211 | Furin-like cysteine rich region | Furin-like cysteine rich region |
| Disorder & Mutation |
| Source |
Disease |
| SWISS-PROT | Hereditary diffuse gastric cancer (HDGC) [MIM:137215]: A cancer predisposition syndrome with increased susceptibility to diffuse gastric cancer. Diffuse gastric cancer is a malignant disease characterized by poorly differentiated infiltrating lesions resulting in thickening of the stomach. Malignant tumors start in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. Note=The gene represented in this entry is involved in disease pathogenesis |
| SWISS-PROT | Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. Note=The gene represented in this entry is involved in disease pathogenesis |
| SWISS-PROT | Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry |
| SWISS-PROT | Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note=The gene represented in this entry is involved in disease pathogenesis |
| SWISS-PROT | Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. Note=The gene represented in this entry is involved in disease pathogenesis |
